- Home
- AMZE vs VRAX Comparison
AMZE vs VRAX Comparison
Compare AMZE & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMZE
- VRAX
- Stock Information
- Founded
- AMZE 2019
- VRAX 2013
- Country
- AMZE United States
- VRAX United Kingdom
- Employees
- AMZE N/A
- VRAX N/A
- Industry
- AMZE Beverages (Production/Distribution)
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMZE Consumer Staples
- VRAX Health Care
- Exchange
- AMZE Nasdaq
- VRAX Nasdaq
- Market Cap
- AMZE 5.2M
- VRAX 4.7M
- IPO Year
- AMZE 2021
- VRAX 2022
- Fundamental
- Price
- AMZE $10.00
- VRAX $0.81
- Analyst Decision
- AMZE
- VRAX Strong Buy
- Analyst Count
- AMZE 0
- VRAX 1
- Target Price
- AMZE N/A
- VRAX $3.00
- AVG Volume (30 Days)
- AMZE 71.2K
- VRAX 37.2K
- Earning Date
- AMZE 08-13-2025
- VRAX 02-05-2025
- Dividend Yield
- AMZE N/A
- VRAX N/A
- EPS Growth
- AMZE N/A
- VRAX N/A
- EPS
- AMZE N/A
- VRAX N/A
- Revenue
- AMZE $254,711.00
- VRAX $84,872.00
- Revenue This Year
- AMZE N/A
- VRAX $5,169.18
- Revenue Next Year
- AMZE N/A
- VRAX $66.97
- P/E Ratio
- AMZE N/A
- VRAX N/A
- Revenue Growth
- AMZE N/A
- VRAX 7.03
- 52 Week Low
- AMZE $5.78
- VRAX $0.75
- 52 Week High
- AMZE $28.72
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- AMZE N/A
- VRAX 31.75
- Support Level
- AMZE N/A
- VRAX $0.75
- Resistance Level
- AMZE N/A
- VRAX $0.85
- Average True Range (ATR)
- AMZE 0.00
- VRAX 0.07
- MACD
- AMZE 0.00
- VRAX -0.01
- Stochastic Oscillator
- AMZE 0.00
- VRAX 6.57
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.